How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

285 results for

Baclofen Withdrawal

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. CRACKCast E206 – Seizures

patient back from the brink. See both Box 15.2 and 15.3 in Rosen’s 9th Edition for more a more comprehensive differential for the patient with status epilepticus. Metabolic Disturbances Hepatic encephalopathy Hypocalcemia Hypoglycemia or hyperglycemia Hyponatremia Uremia Infectious Processes Central nervous system abscess Encephalitis Meningitis Withdrawal Syndromes Alcohol Antiepileptic drugs Baclofen Barbiturates Benzodiazepines Central Nervous System Lesions Acute hydrocephalus Anoxic or hypoxic

2019 CandiEM

86. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutritio

articles assessed for eligibility (n = 59) Full-text articles excluded, with reasons (n = 12) Not assessing one of predefined outcome measures Original studies, n = 22 - Alginates/antacids, n=4 (antacid vs H2RA, n = 2) - H2RAs, n = 8 (n= 2 H2RA vs PPI, n = 2 H2RA vs antacid, n=1 H2RA vs sucralfate) - PPIs, n = 10 (n=2 PPI vs H2RA) - Baclofen, n = 1 - Domperidone, n = 2 - Metoclopramide, n = 2 (n = 1 metocplopramide vs domperidone) Systematic Reviews, n = 25 FIGURE 3. Flow-chart to identify articles

2018 North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition

87. Alcoholic Liver Disease

hospitalized with ALD include inpatient management of liver disease complications, management of alcohol withdrawal syndrome, surveillance for infections and early effective antibiotic therapy, nutritional supplementation, and treatment of the underlying alcohol-use disorder. Liver transplantation, a de? nitive treatment option in patients with advanced alcoholic cirrhosis, may also be considered in selected patients with AH cases, who do not respond to medical therapy. There is a clinical unmet need (...) , low level of evidence) Management of alcoholic liver disease Management of alcohol use disorder 4. In patients with ALD, baclofen is effective in preventing alcohol relapse (Conditional recommendation, low level of evidence) 5. In patients with ALD, brief motivational interventions are effective in reducing alcohol relapse compared with no intervention (Conditional recommenda- tion, very low level of evidence) Alcoholic hepatitis Treatment of alcoholic hepatitis 6. Patients with AH should

2018 American College of Gastroenterology

88. Palliative Care for the Patient with Incurable Cancer or Advanced Disease: Part 2: Pain and Symptom Management

accident • Radiculopathy Generalized Weakness • Deconditioning • Paraneoplastic syndrome • Polymyalgia • Polymyositis • Steroid induced myopathy • Steroid withdrawal, abrupt Reversible Causes of Fatigue (A3) • Anemia • Dehydration • Hypokalemia • Hyponatremia • Hypomagnesemia • Hypo/hypercalcemia • Hypothyroidism • Medicationinduced • Alcohol/drugabuse • Infection • Sleepdisorder • Obstructive sleep apnea • Chronic fatigue syndrome Distinguish fatigue from depression See BCGuidelines.ca – Palliative

2017 Clinical Practice Guidelines and Protocols in British Columbia

89. Motor neurone disease: assessment and management

medicine (for example, if they have problems swallowing). [new 2016] [new 2016] 1.8.2 Consider quinine [1] as first-line treatment for muscle cramps in people with MND. If quinine is not effective, not tolerated or contraindicated, consider baclofen [1] instead as second-line treatment. If baclofen is not effective, not tolerated or contraindicated, consider tizanidine [1] , dantrolene [1] or gabapentin [1] . [new 2016] [new 2016] 1.8.3 Consider baclofen, tizanidine, dantrolene [1] or gabapentin [1

2016 National Institute for Health and Clinical Excellence - Clinical Guidelines

91. Spasticity in adults: management using botulinum toxin - 2nd edition

or (less commonly) nerve blockade with phenol in aqueous solution are the pharmacological treatments of choice for focal spasticity. • If spasticity causes multi-focal problems, BoNT-A may again be helpful, but dose limitations may reduce its long-term effectiveness and additional strategies such as intrathecal baclofen, or a combination of BoNT-A and phenol can be considered. • Oral anti-spasmodic agents (eg baclofen, tizanidine) may be considered for generalised or segmental spasticity but frequently (...) carry the unwanted side effects of drowsiness and muscle weakness. © Royal College of Physicians 2018 7Spasticity in adults: management using botulinum toxin However, it is not uncommon to have a mixed pattern of spasticity with both focal and generalised elements. In practice, interventions are often combined – for example BoNT-A may be given to target a specific problem (eg difficulty maintaining hand hygiene) while baclofen is prescribed to manage a background of spasticity. Fig 2 provides

2018 British Society of Rehabilitation Medicine

92. Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: De-escalation and rapid tranquillisation

Intramuscular antipsychotics in combination with other medications 18 Intravenous 18 Adverse effects 19 From evidence to practice 19 Other interventions 19 Promethazine 19 Loxapine 20 Levomepromazine 20 Zuclopenthixol acetate 21 Dexmedetomidine 22 Barbiturates 22 Valproate 22 Ketamine 22 Electroconvulsive therapy 23 From evidence to practice 24 Modifiers, special settings and circumstances 24 Pregnancy 24 Intoxication and withdrawal 25 Rapid tranquillisation in the general hospital 26 Psychiatric intensive (...) is due to alcohol withdrawal, then the use of benzodiazepines over antip- sychotics is advised. If a psychiatric disorder is causing the acute disturbance, antipsychotic medication is recommended for psy- chotic agitation whereas benzodiazepines should be considered for non-psychotic agitation. The route of medication administra- tion will depend on the severity of the scenario and the degree of patient cooperation, prioritising non-invasive formulations (oral or inhaled) over IM/IV routes

2018 British Association for Psychopharmacology

95. Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis Full Text available with Trip Pro

of healthcare-associated ventriculitis and meningitis, specifically addressing the approach to infections associated with cerebrospinal fluid shunts, cerebrospinal fluid drains, intrathecal drug (eg, baclofen) therapy, deep brain stimulation hardware, and neurosurgery and head trauma. These infections may be difficult to diagnose because changes in cerebrospinal fluid parameters are often subtle, making it hard to determine if the abnormalities are related to infection, related to placement of devices (...) for a maximum of 5 days, sterile reconnection after disconnection or fracture of the drain, and permanent removal of the drain after a second disconnection or fracture. Intrathecal Infusion Pumps Administration of drug therapy (eg, baclofen) via intrathecal infusion pumps has been successful for patients with intractable spasticity, most commonly in patients with cerebral palsy but also in patients with spasticity from multiple sclerosis, trauma, hereditary spastic paraplegia, and a variety of other

2017 Infectious Diseases Society of America

96. Joint NASPGHAN and ESPGHAN guidelines on Gastro-oesophageal Reflux Disease in Children

vs H2RA, n = 2) - H2RAs, n = 8 (n= 2 H2RA vs PPI, n = 2 H2RA vs antacid, n=1 H2RA vs sucralfate) - PPIs, n = 10 (n=2 PPI vs H2RA) - Baclofen, n = 1 - Domperidone, n = 2 - Metoclopramide, n = 2 (n = 1 metocplopramide vs domperidone) Systematic Reviews, n = 25 FIGURE 3. Flow-chart to identify articles related to pharmacologic therapies. JPGN Volume 66, Number 3, March 2018 Pediatric Gastroesophageal Reflux Clinical Practice Guidelines www.jpgn.org 521 Copyright © ESPGHAN and NASPGHAN. All rights

2018 British Society of Paediatric Gastroenterology Hepatology and Nutrition

97. Alcohol: Adult Unhealthy Drinking

of Alcohol Craving and Alcohol Use Disorder 17 Management of Alcohol Withdrawal 20 Evidence Summary 27 References 30 Guideline Development Process and Team 32 Appendix 1a. Talking Points for Brief Interventions: Men and Non-pregnant/Non-lactating Women ... 33 Appendix 1b. Talking Points for Brief Interventions: Pregnant and Lactating Women 35 Appendix 2. Full AUDIT 36 Appendix 3. Self-Assessment Tools 37 Last guideline approval: October 2016 Guidelines are systematically developed statements to assist (...) recommended unless the risks clearly outweigh the benefits. • Risks to the infant can be mitigated by the mother waiting at least 2 hours to breastfeed after one standard drink, or 4–8 hours after consuming more than one drink. Added new tool for assessing the SEVERITY OF ALCOHOL WITHDRAWAL: • The Short Alcohol Withdrawal Scale (SAWS) can be used to assess the severity of alcohol withdrawal and help determine the appropriate setting for management of withdrawal symptoms and the need for medical management

2016 Kaiser Permanente Clinical Guidelines

98. Use of licensed medicines for unlicensed applications in psychiatric practice 2nd edition

. Tell other health professionals involved in the care of the patient that the medicine is being prescribed outside the terms of its licence and encourage them to discuss their observations of its beneficial and untoward effects. 10. If the medicine has no beneficial effects or the emergent risks and hazards outweigh the benefits, withdraw it (generally, best done gradually) and document the reasons why it is being withdrawn. If there is a persistent need for further treatment, consider possible (...) provided an exceptional measure for making medicinal products available before formal marketing authorisation, in situations where there is a genuine public health need (as is cur- rently the case for baclofen in the treatment of alcohol dependence). In the USA, the US Food and Drug Administration (FDA) approves new medicines that are shown to be safe and effective for specific indications, but it does not control or restrict how medicines are pre- scribed once they become available: unlicensed or ‘off

2017 British Association for Psychopharmacology

99. Idelvion (lbutrepenonacog alfa) - haemophilia B

) of isotonic saline (0.9 %), mimicking the highest dose volume used for test substance administration. Baclofen at a dose of 15 mg/kg, was administered to a further group of animals

2016 European Medicines Agency - EPARs

100. Spasticity in under 19s: management

to avoid withdrawal symptoms. 1.4.10 In children and young people with spasticity in whom dystonia is considered to contribute significantly to problems with posture, function and pain, consider a trial of oral drug treatment, for example with trihexyphenidyl [2] , levodopa [3] or baclofen [4] . Spasticity in under 19s: management (CG145) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 24 of 411.5 Botulinum toxin type (...) type A 7 Constraint-induced movement therapy 7 Continuous pump-administered intrathecal baclofen treatment 7 Contracture 7 Dystonia 7 Equinus deformity 7 Fine motor function 7 Focal dystonia 8 Focal spasticity 8 Function 8 Gait analysis 8 Gross motor function 8 Gross Motor Function Classification System 8 Hip migration 8 Intrathecal baclofen testing 9 Kyphosis 9 Low-load active stretching 9 Low-load passive stretching 9 Muscle tone 9 Network of care 9 Network team 9 Orthosis (plural, orthoses) 10

2012 National Institute for Health and Clinical Excellence - Clinical Guidelines

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>